Vyrix Pharmaceuticals Overview
- Founded
-
2013
- Status
-
Acquired/Merged
- Latest Deal Type
-
Merger of Eq.
- Financing Rounds
-
2
Vyrix Pharmaceuticals General Information
Description
Developer of pharmaceutical products. The company engages in developing and commercializing late-stage prescription pharmaceuticals. It develops Zertane™, an oral drug in late stage development as a proprietary treatment for premature ejaculation. It is also developing a combination product with Zertane and an erectile dysfunction product to address co-morbid PE and erectile dysfunction.
Contact Information
Website
www.vyrixpharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 5445 DTC Parkway
- Suite 925
- Greenwood Village, CO 80111
- United States
Vyrix Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vyrix Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|